[HTML][HTML] Functionalized liposomes for targeted breast cancer drug delivery
Despite the exceptional progress in breast cancer pathogenesis, prognosis, diagnosis, and
treatment strategies, it remains a prominent cause of female mortality worldwide …
treatment strategies, it remains a prominent cause of female mortality worldwide …
An update on the pathological classification of breast cancer
EA Rakha, GM Tse, CM Quinn - Histopathology, 2023 - Wiley Online Library
Breast cancer (BC) is a heterogeneous disease, encompassing a diverse spectrum of
tumours with varying morphological, biological, and clinical phenotypes. Although tumours …
tumours with varying morphological, biological, and clinical phenotypes. Although tumours …
Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update
KH Allison, MEH Hammond, M Dowsett… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To update key recommendations of the American Society of Clinical
Oncology/College of American Pathologists estrogen (ER) and progesterone receptor (PgR) …
Oncology/College of American Pathologists estrogen (ER) and progesterone receptor (PgR) …
Estrogen and progesterone receptor testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists guideline update
KH Allison, MEH Hammond… - … of pathology & …, 2020 - meridian.allenpress.com
Purpose.—To update key recommendations of the American Society of Clinical
Oncology/College of American Pathologists estrogen receptor (ER) and progesterone …
Oncology/College of American Pathologists estrogen receptor (ER) and progesterone …
[HTML][HTML] 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
Highlights•This ESO-ESMO ABC 5 Clinical Practice Guideline provides key
recommendations for managing advanced breast cancer patients.•It provides updates on …
recommendations for managing advanced breast cancer patients.•It provides updates on …
[HTML][HTML] Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast …
ABSTRACT The 14th St Gallen International Breast Cancer Conference (2015) reviewed
substantial new evidence on locoregional and systemic therapies for early breast cancer …
substantial new evidence on locoregional and systemic therapies for early breast cancer …
[HTML][HTML] Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
MJ Duffy, N Harbeck, M Nap, R Molina… - European journal of …, 2017 - Elsevier
Biomarkers play an essential role in the management of patients with invasive breast
cancer. For selecting patients likely to respond to endocrine therapy, both oestrogen …
cancer. For selecting patients likely to respond to endocrine therapy, both oestrogen …
Report on computational assessment of tumor infiltrating lymphocytes from the International Immuno-Oncology Biomarker Working Group
Assessment of tumor-infiltrating lymphocytes (TILs) is increasingly recognized as an integral
part of the prognostic workflow in triple-negative (TNBC) and HER2-positive breast cancer …
part of the prognostic workflow in triple-negative (TNBC) and HER2-positive breast cancer …
[КНИГА][B] Game-theoretical models in biology
Covering the major topics of evolutionary game theory, Game-Theoretical Models in Biology,
Second Edition presents both abstract and practical mathematical models of real biological …
Second Edition presents both abstract and practical mathematical models of real biological …
Updates on breast biomarkers
S Najjar, KH Allison - Virchows Archiv, 2022 - Springer
Recent advancements in breast cancer treatment have ushered in a new era of precision
medicine. Novel trials have led to the approval of a growing list of personalized therapies …
medicine. Novel trials have led to the approval of a growing list of personalized therapies …